Glucocorticosteroids modify Langerhans cells to produce TGF-β and expand regulatory T cells

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 103-112

  Stary, Georg ^a   Klein, Irene ^a   Bauer, Wolfgang ^a   Koszik, Frieder ^a   Reininger, Bärbel ^a   Kohlhofer, Sabine ^a   Gruber, Kristina ^a   Skvara, Hans ^a   Jung, Thomas ^b   Stingl, Georg ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PLACEBO; PREDNISONE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EXPOSURE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFANT; LANGERHANS CELL; LYMPHOCYTE COUNT; MALE; PATCH TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLERGY; SKIN BIOPSY; UPREGULATION;

ADMINISTRATION, ORAL; ADULT; ALLERGENS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LANGERHANS CELLS; MALE; MIDDLE AGED; NICKEL; PATCH TESTS; PREDNISONE; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 79251577059     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002485     Document Type: Article

References (68)

1. Leung, D. Y., and J. W. Bloom. 2003. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 111: 3-22, quiz 23.
2. Gilroy, D. W., T. Lawrence, M. Perretti, and A. G. Rossi. 2004. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3: 401-416.
3. Refojo, D., A. C. Liberman, F. Holsboer, and E. Arzt. 2001. Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids. Immunol. Cell Biol. 79: 385-394.
4. Rhen, T., and J. A. Cidlowski. 2005. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 353: 1711-1723.
5. Ashwell, J. D., F. W. Lu, and M. S. Vacchio. 2000. Glucocorticoids in T cell development and function*. Annu. Rev. Immunol. 18: 309-345.
6. Paliogianni, F., S. S. Ahuja, J. P. Balow, J. E. Balow, and D. T. Boumpas. 1993. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 151: 4081-4089.
7. Almawi, W. Y., H. N. Beyhum, A. A. Rahme, and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60: 563-572.
8. Vanderheyde, N., V. Verhasselt, M. Goldman, and F. Willems. 1999. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 67: 1342-1347.
9. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
10. Von Stebut, E., J. M. Ehrchen, Y. Belkaid, S. L. Kostka, K. Molle, J. Knop, C. Sunderkotter, and M. C. Udey. 2003. Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J. Exp. Med. 198: 191-199.
11. van Beelen, A. J., Z. Zelinkova, E. W. Taanman-Kueter, F. J. Muller, D. W. Hommes, S. A. Zaat, M. L. Kapsenberg, and E. C. de Jong. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27: 660-669.
12. Soumelis, V., P. A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3: 673-680.
13. Jonuleit, H., E. Schmitt, G. Schuler, J. Knop, and A. H. Enk. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
14. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.
15. Yamazaki, S., T. Iyoda, K. Tarbell, K. Olson, K. Velinzon, K. Inaba, and R. M. Steinman. 2003. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198: 235-247.
16. Schwarz, A., M. Noordegraaf, A. Maeda, K. Torii, B. E. Clausen, and T. Schwarz. 2010. Langerhans cells are required for UVR-induced immunosuppression. J. Invest. Dermatol. 130: 1419-1427.
17. Yoshiki, R., K. Kabashima, K. Sugita, K. Atarashi, T. Shimauchi, and Y. Tokura. 2009. IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J. Invest. Dermatol. 129: 705-713.
18. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger, and S. Beissert. 2006. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12: 1372-1379.
19. Theill, L. E., W. J. Boyle, and J. M. Penninger. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20: 795-823.
20. Unger, W. W., S. Laban, F. S. Kleijwegt, A. R. van der Slik, and B. O. Roep. 2009. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39: 3147-3159.
21. Turnquist, H. R., G. Raimondi, A. F. Zahorchak, R. T. Fischer, Z. Wang, and A. W. Thomson. 2007. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol. 178: 7018-7031.
22. Rea, D., C. van Kooten, K. E. van Meijgaarden, T. H. Ottenhoff, C. J. Melief, and R. Offringa. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95: 3162-3167. (Pubitemid 30321168)
23. Xia, C. Q., R. Peng, F. Beato, and M. J. Clare-Salzler. 2005. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 62: 45-54.
24. Woltman, A. M., J. W. de Fijter, S. W. Kamerling, L. C. Paul, M. R. Daha, and C. van Kooten. 2000. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30: 1807-1812.
25. Roelen, D. L., D. H. Schuurhuis, D. E. van den Boogaardt, K. Koekkoek, P. P. van Miert, J. J. van Schip, S. Laban, D. Rea, C. J. Melief, R. Offringa, et al. 2003. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76: 1608-1615.
26. Emmer, P. M., J. van der Vlag, G. J. Adema, and L. B. Hilbrands. 2006. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 81: 1451-1459.
27. Chen, X., T. Murakami, J. J. Oppenheim, and O. M. Howard. 2004. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur. J. Immunol. 34: 859-869.
28. Chen, X., J. J. Oppenheim, R. T. Winkler-Pickett, J. R. Ortaldo, and O. M. Howard. 2006. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 36: 2139-2149.
29. Hamdi, H., V. Godot, M. C. Maillot, M. V. Prejean, N. Cohen, R. Krzysiek, F. M. Lemoine, W. Zou, and D. Emilie. 2007. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 110: 211-219.
30. Braitch, M., S. Harikrishnan, R. A. Robins, C. Nichols, A. J. Fahey, L. Showe, and C. S. Constantinescu. 2009. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol. Scand. 119: 239-245.
31. Ling, Y., X. Cao, Z. Yu, and C. Ruan. 2007. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur. J. Haematol. 79: 310-316.
32. Karagiannidis, C., M. Akdis, P. Holopainen, N. J. Woolley, G. Hense, B. Rückert, P. Y. Mantel, G. Menz, C. A. Akdis, K. Blaser, and C. B. Schmidt-Weber. 2004. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114: 1425-1433.
33. Stary, G., C. Bangert, M. Tauber, R. Strohal, T. Kopp, and G. Stingl. 2007. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med. 204: 1441-1451.
34. Jaksits, S., E. Kriehuber, A. S. Charbonnier, K. Rappersberger, G. Stingl, and D. Maurer. 1999. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J. Immunol. 163: 4869-4877.
35. Stary, G., I. Klein, M. C. Brüggen, S. Kohlhofer, P. M. Brunner, D. Spazierer, L. Müllauer, P. Petzelbauer, and G. Stingl. 2010. Host defense mechanisms in secondary syphilitic lesions: a role for IFN-{gamma}-/IL-17- producing CD8+ T cells? Am. J. Pathol. 177: 2421-2432.
36. Geissmann, F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. Amigorena, O. Hermine, and A. Durandy. 1999. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162: 4567-4575. (Pubitemid 29314856)
37. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360: 258-261.
38. Tsai, Y. G., K. D. Yang, D. M. Niu, J. W. Chien, and C. Y. Lin. 2010. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy. J. Immunol. 184: 7229-7237.
39. Romani, N., S. Ebner, C. H. Tripp, V. Flacher, F. Koch, and P. Stoitzner. 2006. Epidermal Langerhans cells - changing views on their function in vivo. Immunol. Lett. 106: 119-125.
40. Stingl, G., S. I. Katz, E. M. Shevach, A. S. Rosenthal, and I. Green. 1978. Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. J. Invest. Dermatol. 71: 59-64.
41. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161: 526-546.
42. Toews, G. B., P. R. Bergstresser, and J. W. Streilein. 1980. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124: 445-453.
43. Mayerova, D., E. A. Parke, L. S. Bursch, O. A. Odumade, and K. A. Hogquist. 2004. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21: 391-400.
44. Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M. G. Manz, S. A. Lira, I. Charo, D. N. Cook, I. L. Weissman, S. Strober, and E. G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10: 510-517.
45. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169: 569-576.
46. Grabbe, S., K. Steinbrink, M. Steinert, T. A. Luger, and T. Schwarz. 1995. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J. Immunol. 155: 4207-4217.
47. Allan, R. S., C. M. Smith, G. T. Belz, A. L. van Lint, L. M. Wakim, W. R. Heath, and F. R. Carbone. 2003. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
48. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, and A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162.
49. Ritter, U., A. Meissner, C. Scheidig, and H. Körner. 2004. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol. 34: 1542-1550.
50. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
51. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620.
52. Senechal, B., G. Elain, E. Jeziorski, V. Grondin, N. Patey-Mariaud de Serre, F. Jaubert, K. Beldjord, A. Lellouch, C. Glorion, M. Zerah, et al. 2007. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med. 4: e253.
53. Aberer, W., L. Stingl, S. Pogantsch, and G. Stingl. 1984. Effect of glucocorticosteroids on epidermal cell-induced immune responses. J. Immunol. 133: 792-797. (Pubitemid 14093470)
54. Furue, M., and S. I. Katz. 1989. Direct effects of glucocorticosteroids on epidermal Langerhans cells. J. Invest. Dermatol. 92: 342-347.
55. Belsito, D. V., T. J. Flotte, H. W. Lim, R. L. Baer, G. J. Thorbecke, and I. Gigli. 1982. Effect of glucocorticosteroids on epidermal Langerhans cells. J. Exp. Med. 155: 291-302.
56. Hoetzenecker, W., J. G. Meingassner, R. Ecker, G. Stingl, A. Stuetz, and A. Elbe-Bürger. 2004. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J. Invest. Dermatol. 122: 673-684.
57. Hoetzenecker, W., R. Ecker, T. Kopp, A. Stuetz, G. Stingl, and A. Elbe-Bürger. 2005. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 115: 1276-1283.
58. Halliday, G. M., B. A. Knight, and H. K. Muller. 1986. Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants. Br. J. Dermatol. 114: 83-89.
59. Woltman, A. M., C. Massacrier, J. W. de Fijter, C. Caux, and C. van Kooten. 2002. Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. J. Immunol. 168: 6181-6188.
60. Meindl, S., C. Vaculik, J. G. Meingassner, G. Kramer, J. Akgün, M. Prior, A. Stuetz, G. Stingl, and A. Elbe-Bürger. 2009. Differential effects of corticosteroids and pimecrolimus on the developing skin immune system in humans and mice. J. Invest. Dermatol. 129: 2184-2192.
61. Chorro, L., A. Sarde, M. Li, K. J. Woollard, P. Chambon, B. Malissen, A. Kissenpfennig, J. B. Barbaroux, R. Groves, and F. Geissmann. 2009. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 206: 3089-3100.
62. Kaplan, D. H., M. O. Li, M. C. Jenison, W. D. Shlomchik, R. A. Flavell, and M. J. Shlomchik. 2007. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204: 2545-2552.
63. Barbaroux, J. B., M. Beleut, C. Brisken, C. G. Mueller, and R. W. Groves. 2008. Epidermal receptor activator of NF-kappaB ligand controls Langerhans cells numbers and proliferation. J. Immunol. 181: 1103-1108.
64. Schwarz, A., A. Maeda, M. K. Wild, K. Kernebeck, N. Gross, Y. Aragane, S. Beissert, D. Vestweber, and T. Schwarz. 2004. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol. 172: 1036-1043. (Pubitemid 38113763)
65. Schwarz, A., A. Maeda, and T. Schwarz. 2007. Alteration of the migratory behavior of UV-induced regulatory T cells by tissue-specific dendritic cells. J. Immunol. 178: 877-886.
66. Larregina, A. T., A. E. Morelli, L. A. Spencer, A. J. Logar, S. C. Watkins, A. W. Thomson, and L. D. Falo, Jr. 2001. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2: 1151-1158.
67. Lukas, M., H. Stössel, L. Hefel, S. Imamura, P. Fritsch, N. T. Sepp, G. Schuler, and N. Romani. 1996. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 106: 1293-1299.
68. Bertoglio, J. H., and E. Leroux. 1988. Differential effects of glucocorticoids on the proliferation of a murine helper and a cytolytic T cell clone in response to IL-2 and IL-4. J. Immunol. 141: 1191-1196.